A Novel Mobile Health Intervention for Improving Tobacco Cessation Among Young Adults (NCT07571018) | Clinical Trial Compass
RecruitingNot Applicable
A Novel Mobile Health Intervention for Improving Tobacco Cessation Among Young Adults
United States140 participantsStarted 2026-06-07
Plain-language summary
Tobacco use is the leading cause of preventable cancer deaths. Among young adults, approximately 1 in 5 use commercial nicotine and tobacco products, putting them at risk of developing nicotine addiction and long-term health effects from exposure to toxicants. Innovative approaches are needed to engage young adults in treatment, as they are less engaged in traditional treatment.
This clinical trial compares two versions of a mobile health intervention called Living Free from Tobacco (LiFT), designed to support nicotine and tobacco cessation among young adults. Both versions of the app are designed to motivate and support young adults to stop using nicotine and tobacco, regardless of current readiness to quit. Version A of the LiFT app (LiFT A) focuses on increasing psychological flexibility to support cessation, while Version B (LiFT B) provides educational content and resources related to tobacco use and cessation. Both versions of the program are delivered through a smartphone application and include accompanying text messages.
Who can participate
Age range
18 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must self-identify being between 18 and 30 years of age
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must be a United States (US) resident, with a US mailing address
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must self-report use of any (non-therapeutic) nicotine or tobacco product at least once per week in the 30 days prior to screening
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must own a smartphone
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must self-report having internet access for the interviews
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must self-report that they are interested in participating in the study for themselves (versus \[vs\] someone else)
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must self-report that they have not participated in one of our prior tobacco cessation studies
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must self-report that they understand and agree to the conditions of compensation
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must self-report that they are not currently incarcerated
* USER-CENTERED DESIGN AND PROGRAM DEVELOPMENT: Participants must be willing and able to complete study procedures in English
* PILOT TRIAL: Participants must self-identify being between 18 and 30 years of age
* PILOT TRIAL: Participants must cur…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial seems focused on testing a mobile app and text messages rather than a medication or medical procedure — does that mean it's mainly gathering feedback on whether the program is easy to use and satisfying, rather than proving it actually helps people quit smoking?
2Since this is described as a pilot trial with no listed phase, what does that mean for how much we already know about whether this approach works, and should I consider more established quit-smoking treatments first?
3The trial is measuring things like how often people log into the app and whether they'd recommend it to a friend — given that these are the main outcomes being tracked, how confident can we be that joining this study would directly support my own quit attempt?
4This study appears to target young adults specifically — is my age, smoking history, or current level of tobacco use something that would affect whether this kind of digital intervention might or might not be a good fit for me?
5Are there proven tobacco cessation options, like counseling, nicotine replacement, or prescription medications, that I should try alongside or instead of this trial, especially since the trial is still in a very early testing stage?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Overall satisfaction (Pilot trial phase)
Timeframe: At 3 months
2
Number of logins to assigned application (Pilot trial phase)
Timeframe: At 3 months
3
Usefulness of the program (Pilot trial phase)
Timeframe: At 3 months
4
Usefulness of text messages (Pilot trial phase)
Timeframe: At 3 months
5
Satisfaction with perceived tailoring (Pilot trial phase)
Timeframe: At 3 months
6
Satisfaction with guidance on how to quit (Pilot trial phase)
Timeframe: At 3 months
7
Perception that program offered a novel approach to quitting (Pilot trial phase)